Browsing Tag
Pharma acquisition news
231 posts
Lilly to acquire gene therapy firm Akouos to discover hearing loss treatments
Lilly acquisition of Akouos : American pharmaceutical giant Eli Lilly and Company (Lilly) has agreed to acquire precision…
LG Chem to acquire US biotech company Aveo Oncology for $566m
LG Chem acquisition of Aveo Oncology : South Korea’s LG Chem has entered into a definitive agreement to…
Novo Nordisk acquires SCD drug developer Forma Therapeutics
Novo Nordisk acquisition of Forma Therapeutics : Danish pharma company Novo Nordisk has closed the previously announced $1.1…
Alexion to acquire genetic medicine company LogicBio Therapeutics
Alexion, AstraZeneca Rare Disease has agreed to acquire LogicBio Therapeutics, an American clinical-stage genetic medicine company in a…
Torrent Pharmaceuticals completes ₹2,000 crore Curatio Healthcare acquisition to expand India’s cosmetic dermatology portfolio
Torrent Pharmaceuticals completes ₹2,000 crore acquisition of Curatio Healthcare, adding 50+ cosmetic dermatology brands and 600 MRs to boost growth.
Idera Pharmaceuticals acquires rare orphan disease company Aceragen
Idera Pharmaceuticals, a US-based biopharma company, has acquired Aceragen, a biotechnology company focused on developing drugs for rare,…
Torrent Pharmaceuticals to acquire dermatology company Curatio Healthcare for Rs 20bn
Indian pharma company Torrent Pharmaceuticals has agreed to acquire cosmetic dermatology company Curatio Healthcare (I) Private Limited for…
Sartorius to acquire recombinant albumin-based solutions provider Albumedix
Sartorius Group, a German pharma and lab equipment supplier, through its French listed subgroup Sartorius Stedim Biotech, has…
Pfizer to acquire Oxbryta developer Global Blood Therapeutics for $5.4bn
Pfizer has agreed to acquire Global Blood Therapeutics (GBT), a publicly-listed American biopharma company, in a deal worth…
Gilead Sciences to acquire British biotech company MiroBio for $405m
Gilead Sciences has agreed to acquire MiroBio, a clinical-stage British biotech company, in an all-cash deal worth around…